BB

Bernina BioInvest

Europe, Zug, Switzerland, Zug

Description

Bernina BioInvest is an investment Firm.

Investor Profile

Bernina BioInvest has made 13 investments, with 0 in the past 12 months and 23% as lead.

Stage Focus

  • Seed (69%)
  • Series A (15%)
  • Series Unknown (8%)
  • Series B (8%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Artificial Intelligence (Ai)
  • Bioinformatics
  • Information Technology
  • Machine Learning
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bernina BioInvest frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 1
Apollo Health Ventures
Europe, Hamburg, Germany, Hamburg
Co-Investments: 3
Aargauische Kantonalbank
Europe, Aargau, Switzerland, Aarau
Co-Investments: 2
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 2
4See Ventures
Europe, Geneve, Switzerland, Secheron
Co-Investments: 3
Broadview Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3
Viva BioInnovator
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Schroder Adveq
Europe, Zurich, Switzerland, Zürich
Co-Investments: 6

Which angels does Bernina BioInvest often collaborate with?

DV
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1
RA
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1

What are some of recent deals done by Bernina BioInvest?

Versameb

Basel, Basel-Stadt, Switzerland

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

BiotechnologyMedicalPharmaceutical
SeedJun 14, 2023
Amount Raised: $9,982,171
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedFeb 9, 2022
Amount Raised: $5,000,000
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedMay 20, 2021
Amount Raised: $20,053,856
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedMay 5, 2021
Amount Raised: $18,000,000
Synendos Therapeutics

Allschwil, Basel-Landschaft, Switzerland

Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.

Health CareMedicalTherapeutics
Series ANov 12, 2020
Amount Raised: $21,860,671
Memo Therapeutics

Schlieren, Zurich, Switzerland

Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.

BiotechnologyCollaboration
Series BNov 6, 2020
Amount Raised: $15,551,288
Versameb

Basel, Basel-Stadt, Switzerland

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

BiotechnologyMedicalPharmaceutical
SeedJul 15, 2020
Amount Raised: $6,355,259
ELDICO Scientific

Villigen, Aargau, Switzerland

ELDICO develops, produces and sells electron diffractometers for the analysis of solid chemical compounds.

BiopharmaNanotechnology
SeedMay 7, 2020
Amount Raised: $1,541,624
ImmunOs Therapeutics

Schlieren, Zurich, Switzerland

ImmunOs Therapeutics is a clinical-stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series ADec 10, 2019
Amount Raised: $15,235,015
EraCal

Zürich, Zurich, Switzerland

EraCal Therapeutics develops drugs to treat different diseases.

BiotechnologyHealth CarePharmaceutical
SeedOct 18, 2019